FDA Inspection 1254026 — Seattle Reproductive Medicine Inc P.S.
The FDA completed an inspection of Seattle Reproductive Medicine Inc P.S. on Nov 6, 2024 in Everett, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 6, 2024
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Everett, WA (United States)